Ensign Peak Advisors
EPIX

Ensign Peak Advisors’s ESSA Pharma EPIX Stock Holding History

Ensign Peak Advisors’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,282
Closed -$83K – 2321
2022
Q2 		$83K Sell
26,282
-63,166
-71% -$353K ﹤0.01% 1996
2022
Q1 		$552K Hold
89,448
– – ﹤0.01% 1506
2021
Q4 		$1.27M Buy
89,448
+6,380
+8% +$71.1K ﹤0.01% 1159
2021
Q3 		$665K Sell
83,068
-95,000
-53% -$1.51M ﹤0.01% 1561
2021
Q2 		$5.09M Buy
178,068
+19,460
+12% +$566K 0.01% 645
2021
Q1 		$4.61M Buy
158,608
+110,442
+229% +$2.57M 0.01% 657
2020
Q4 		$575K Buy
48,166
+18,569
+63% +$131K ﹤0.01% 1575
2020
Q3 		$204K Buy
+29,597
New +$201K ﹤0.01% 1663

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Ensign Peak Advisors's EPIX Position: Q3 2022 in Review

Ensign Peak Advisors sold out of ESSA Pharma (EPIX) in Q3 2022, closing a stake of 26,282 shares — an estimated $83K sold.

Ensign Peak Advisors first reported a position in EPIX in Q3 2020 and held it in 8 quarters. The position peaked at $5.09M in Q2 2021. 54 funds tracked by Wall St. Rank hold EPIX as of Q3 2022.

  • Ensign Peak Advisors reported no remaining ESSA Pharma position as of Q3 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 26,282 ESSA Pharma shares in Q3 2022, an estimated $83K.
  • Ensign Peak Advisors first reported a position in ESSA Pharma in Q3 2020 and held it in 8 quarters.
  • Ensign Peak Advisors's ESSA Pharma position peaked at $5.09M in Q2 2021.
  • 54 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2022.

Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.